Related Experiment Video
Updated: Aug 1, 2025

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
Association between Multiple Myeloma and Ulcerative Colitis: A Cross-Sectional Analysis
Ayrton Bangolo1, Sowmya Sagireddy1, Paul Desrochers1
1Department of Medicine, Hackensack Meridian Health Palisades Medical Center, North Bergen, NJ 07047, USA.
Ulcerative colitis (UC) patients show a higher prevalence of multiple myeloma (MM), especially in older, obese, and African American males. Increased clinical suspicion for MM is advised in UC patients with these risk factors.
Area of Science:
- Hematology
- Gastroenterology
- Oncology
Background:
- Multiple myeloma (MM) is a plasma cell disorder often seen in autoimmune conditions.
- The link between ulcerative colitis (UC) and MM has not been well-established.
- This study investigates the prevalence of MM in UC patients.
Purpose of the Study:
- To determine the prevalence of multiple myeloma (MM) in patients diagnosed with ulcerative colitis (UC).
- To identify demographic subgroups within the UC population that exhibit a higher risk for MM.
- To assess the association between UC and MM in a US-based inpatient cohort.
Main Methods:
- A cross-sectional cohort analysis was conducted using the National Inpatient Sample (NIS) database from 2015 to 2018.
- The study compared MM prevalence in patients with and without UC, controlling for age and sex.
- Logistic regression analysis was employed to determine the odds of MM in UC patients.
Main Results:
- Patients with UC had a higher crude prevalence of MM (0.44%) compared to those without UC (0.37%).
- UC patients demonstrated increased odds of having MM (OR, 1.26).
- Higher MM prevalence was observed in UC patients who were male, African American, aged over 64, or obese.
Conclusions:
- Ulcerative colitis (UC) is associated with an increased prevalence of multiple myeloma (MM).
- This association is more pronounced in specific demographics: elderly (>64 years), obese, and African American males with UC.
- Heightened clinical vigilance for MM is recommended in UC patients, particularly those in identified high-risk demographic groups.
More Related Videos
Related Concept Videos
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Drugs for Treatment of Ulcerative Colitis in IBD
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...

